{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:45:25Z","timestamp":1792154725997,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.taap.2004.09.020","type":"journal-article","created":{"date-parts":[[2005,4,7]],"date-time":"2005-04-07T18:05:39Z","timestamp":1112897139000},"page":"131-137","source":"Crossref","is-referenced-by-count":85,"title":["Role of metabolism and viruses in aflatoxin-induced liver cancer"],"prefix":"10.1016","volume":"206","author":[{"given":"John D.","family":"Groopman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Kensler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2004.09.020_bib1","first-page":"245","article-title":"IARC","volume":"56","author":"Aflatoxins","year":"1993","journal-title":"Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.taap.2004.09.020_bib2","first-page":"3","article-title":"Biological markers in environmental health research","volume":"74","author":"Anonymous","year":"1987","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2004.09.020_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2613.2001.iep178.x","volume":"82","author":"Arbuthnot","year":"2001","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.taap.2004.09.020_bib4","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/hep.510290336","volume":"29","author":"Baptista","year":"1999","journal-title":"Hepatology"},{"issue":"6317","key":"10.1016\/j.taap.2004.09.020_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/350429a0","article-title":"Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa","volume":"350","author":"Bressac","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.taap.2004.09.020_bib6","series-title":"Chemical Carcinogens","first-page":"945","article-title":"Aflatxoins","author":"Busby","year":"1984"},{"issue":"6","key":"10.1016\/j.taap.2004.09.020_bib7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/hep.1840160610","article-title":"Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain","volume":"16","author":"Challen","year":"1992","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.taap.2004.09.020_bib8","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1038\/sj.onc.1202214","article-title":"The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts","volume":"17","author":"Denissenko","year":"1998","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.taap.2004.09.020_bib9","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/carcin\/16.8.1769","article-title":"Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz","volume":"16","author":"Egner","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2004.09.020_bib10","doi-asserted-by":"crossref","first-page":"14601","DOI":"10.1073\/pnas.251536898","article-title":"Cancer chemoprevention in humans: chlorophyllin reduces aflatoxin-DNA adducts","volume":"98","author":"Egner","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.taap.2004.09.020_bib11","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1073\/pnas.80.9.2695","article-title":"Base substitution mutations induced by metabolically activated aflatoxin B1","volume":"80","author":"Foster","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"18","key":"10.1016\/j.taap.2004.09.020_bib12","first-page":"4855","article-title":"Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis","volume":"54","author":"Greenblatt","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2004.09.020_bib13","first-page":"211","article-title":"Epidemiology of human aflatoxin and their relationship to liver cancer","volume":"395","author":"Groopman","year":"1996","journal-title":"Prog. Clin. Biol. Res."},{"issue":"Suppl. 3","key":"10.1016\/j.taap.2004.09.020_bib14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1289\/ehp.96104s3435","article-title":"p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment","volume":"104","author":"Harris","year":"1996","journal-title":"Environ. Health Perspect."},{"issue":"5015","key":"10.1016\/j.taap.2004.09.020_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.taap.2004.09.020_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1478-3231.1999.tb00070.x","volume":"19","author":"Hou","year":"1999","journal-title":"Liver"},{"issue":"6317","key":"10.1016\/j.taap.2004.09.020_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/350427a0","article-title":"Mutational hotspot in the p53 gene in human hepatocellular carcinomas","volume":"350","author":"Hsu","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.taap.2004.09.020_bib18","first-page":"33","article-title":"Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry","volume":"61","author":"Jackson","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2004.09.020_bib19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/carcin\/bgg101","article-title":"Prospective detection of codon 249 mutations in p53 in plasma of hepatocellular carcinoma patients","volume":"10","author":"Jackson","year":"2003","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.taap.2004.09.020_bib20","first-page":"257","article-title":"Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes","volume":"6","author":"Jacobson","year":"1997","journal-title":"Cancer Epidemiol., Biomarkers Prev."},{"key":"10.1016\/j.taap.2004.09.020_bib21","first-page":"237","article-title":"Use of carcinogen-DNA and carcinogen\u2013protein adduct biomarkers for cohort selection and as modifiable end points in chemoprevention trials","volume":"139","author":"Kensler","year":"1996","journal-title":"Princ. Chemoprev."},{"key":"10.1016\/j.taap.2004.09.020_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0027-5107(97)00294-7","article-title":"Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man","volume":"402","author":"Kensler","year":"1998","journal-title":"Mutat. Res."},{"issue":"2","key":"10.1016\/j.taap.2004.09.020_bib23","first-page":"127","article-title":"Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers","volume":"7","author":"Kensler","year":"1998","journal-title":"Cancer Epidemiol., Biomarkers Prev."},{"key":"10.1016\/j.taap.2004.09.020_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc1076","article-title":"Hepatocarcinogenesis as a paradigm for cancer prevention","volume":"3","author":"Kensler","year":"2003","journal-title":"Nat. Cancer Rev."},{"key":"10.1016\/j.taap.2004.09.020_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/jnci\/92.2.148","article-title":"Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia","volume":"92","author":"Kirk","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.taap.2004.09.020_bib26","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1073\/pnas.0308232100","article-title":"Specific mutations of hepatitis B virus in plasma predict liver cancer development","volume":"101","author":"Kuang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.taap.2004.09.020_bib27","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","article-title":"Hepatitis B virus infection","volume":"337","author":"Lee","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2004.09.020_bib28","series-title":"P.R.C. Studies on Mortality Rates of Cancer in China","year":"1980"},{"issue":"22","key":"10.1016\/j.taap.2004.09.020_bib29","first-page":"6185","article-title":"Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens","volume":"51","author":"Puisieux","year":"1991","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.taap.2004.09.020_bib30","first-page":"3","article-title":"A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China","volume":"3","author":"Qian","year":"1994","journal-title":"Cancer Epidemiol., Biomarkers Prev."},{"issue":"20","key":"10.1016\/j.taap.2004.09.020_bib31","first-page":"5501","article-title":"Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry","volume":"51","author":"Roebuck","year":"1991","journal-title":"Cancer Res."},{"issue":"8799","key":"10.1016\/j.taap.2004.09.020_bib32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0140-6736(92)91528-G","article-title":"Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma","volume":"339","author":"Ross","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2004.09.020_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.med.47.1.285","article-title":"Clinical implications of the p53 gene","volume":"47","author":"Sidransky","year":"1996","journal-title":"Annu. Rev. Med."},{"issue":"6357","key":"10.1016\/j.taap.2004.09.020_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/355209a0","article-title":"Carcinogens leave fingerprints","volume":"355","author":"Vogelstein","year":"1992","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.taap.2004.09.020_bib35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/(SICI)1097-0215(19960904)67:5<620::AID-IJC5>3.0.CO;2-W","article-title":"Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan","volume":"67","author":"Wang","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2004.09.020_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1289\/ehp.9298167","article-title":"Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research","volume":"98","author":"Wogan","year":"1992","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.taap.2004.09.020_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0168-8278(97)80178-X","article-title":"Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan","volume":"27","author":"Yu","year":"1997","journal-title":"J. Hepatol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X05000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X05000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T11:58:22Z","timestamp":1548590302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X05000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0041008X05000852"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2004.09.020","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}